Short Interest in Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) Declines By 97.9%

Posted by Joseph Casey on Jul 11th, 2026

Croda International PLC Unsponsored ADR (OTCMKTS:COIHY – Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 30th, there was short interest totaling 55 shares, a decrease of 97.9% from the June 15th total of 2,576 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 12,409 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Kepler Capital Markets upgraded shares of Croda International from a “reduce” rating to a “hold” rating in a research note on Tuesday, March 31st. Zacks Research raised Croda International from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. One equities research analyst has rated the stock with a Strong Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Croda International has an average rating of “Moderate Buy”.

Check Out Our Latest Research Report on Croda International

Croda International Price Performance

OTCMKTS:COIHY traded up $0.32 during midday trading on Friday, reaching $19.44. The stock had a trading volume of 12,886 shares, compared to its average volume of 3,752. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.18 and a current ratio of 1.99. The firm has a fifty day simple moving average of $19.83 and a two-hundred day simple moving average of $19.45. Croda International has a 12-month low of $16.26 and a 12-month high of $22.29.

About Croda International

(Get Free Report)

Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.

Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.